QT
CRMD icon

Quantbot Technologies’s CorMedix CRMD Stock Holding History

Quantbot Technologies’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.8K Sell
10,797
-1,768
-14% -$14K ﹤0.01% 1506
2026
Q1 		$85.3K Sell
12,565
-135,249
-91% -$1,000K ﹤0.01% 1344
2025
Q4 		$1.72M Buy
147,814
+90,326
+157% +$999K 0.06% 502
2025
Q3 		$669K Buy
57,488
+41,301
+255% +$499K 0.02% 914
2025
Q2 		$199K Buy
+16,187
New +$179K 0.01% 1241
2024
Q4 		– Sell
-628
Closed -$5.07K – 1539
2024
Q3 		$5.07K Buy
+628
New +$3.4K ﹤0.01% 1370
2022
Q3 		– Sell
-5,600
Closed -$22K – 1670
2022
Q2 		$22K Sell
5,600
-1,400
-20% -$5.2K ﹤0.01% 1438
2022
Q1 		$38K Buy
+7,000
New +$32.1K ﹤0.01% 1251

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quantbot Technologies's CRMD Position: Q2 2026 in Review

Quantbot Technologies reduced its CorMedix (CRMD) stake by 14% in Q2 2026, selling an estimated $14K and leaving 10,797 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

Quantbot Technologies first reported a position in CRMD in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.72M in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Quantbot Technologies held 10,797 shares of CorMedix worth $84.8K as of Q2 2026.
  • Quantbot Technologies sold 1,768 CorMedix shares in Q2 2026, an estimated $14K.
  • CorMedix made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1506 holding.
  • Quantbot Technologies first reported a position in CorMedix in Q1 2022 and has held it in 8 quarters since.
  • Quantbot Technologies's CorMedix position peaked at $1.72M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.